| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals, Inc. (REGN) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 85 sells. REGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Pres | 310.5K | $189.36M | - | |
| CEO | 214.5K | $130.85M | - | |
| VP | 47.8K | $29.18M | - | |
| VP | 29.5K | $18.00M | - | |
| VP | 21.7K | $13.22M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 3, 2022 | Tessier-Lavigne Marc69 | Director | Sale+OE | 10,838 | $702.24 | $7,610,844.04 | -19.0% | -2.0% | +10.0% | |
| Sep 12, 2022 | Van Plew Daniel P | EVP &General Mgr, Industrial | Sale+OE | 4,696 | $716.38 | $3,364,110.65 | -1.0% | +4.5% | +17.2% | |
| Sep 9, 2022 | Bassler Bonnie L59 | Director | Sale+OE | 3,167 | $704.65 | $2,231,624.21 | -49.4% | +5.7% | +14.7% | |
| Sep 6, 2022 | Coles N Anthony | Director | Sale+OE | 6,000 | $581.28 | $3,487,656.69 | -14.6% | +31.6% | +42.6% | |
| Sep 6, 2022 | Ryan Arthur F54 | Director | Sell | 100 | $582.37 | $58,236.73 | - | +31.6% | +42.6% | |
| Sep 1, 2022 | McCourt Marion55 | EVP Commercial | Sale+OE | 1,100 | $577.62 | $635,382.00 | -5.3% | +25.2% | +38.5% | |
| Aug 16, 2022 | Murphy Andrew J54 | EVP Research | Sale+OE | 3,513 | $645.49 | $2,267,600.12 | -0.5% | +14.4% | +22.9% | |
| Aug 9, 2022 | Poon Christine A51 | Director | Sale+OE | 15,000 | $620.91 | $9,313,598.80 | -55.7% | +20.7% | +26.3% | |
| Aug 5, 2022 | Stahl Neil | EVP Research And Development | Sale+OE | 23,782 | $612.61 | $14,569,134.05 | -2.3% | +20.4% | +24.9% | |
| Aug 4, 2022 | Ryan Arthur F54 | Director | Sale+OE | 10,453 | $621.29 | $6,494,318.79 | -15.6% | +20.4% | +24.6% |